ALFA FinderNSE filing, NSE: IIRM. Summary written from the filing by ALFA Finder's alert engine.
IIRM Holdings India Ltd: key numbers
- Share price
- ₹108.40
- Market cap
- ₹738.7 Cr
- Revenue (annual)
- ₹252.2 Cr
- Net profit (annual)
- ₹24.37 Cr
- P/E (TTM)
- 30.2×Sector 46.1×
- Promoter holding
- 56.59%-1.30% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IIRM Holdings India Ltd
All →IIRM Holdings India Q2 FY27 Results: Net Profit ₹5.2 Cr, Up 0.0% YoY
IIRM Holdings India Ltd reported revenue from operations of ₹67.3 Cr (+13.5% YoY) and net profit of ₹5.2 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.2 Cr · +0.0% YoY
IIRM Holdings India Board Meeting Date
IIRM Holdings India Ltd scheduled its Board of Directors meeting for 12 Nov 2026 to approve Q2/H1 results. The trading window is closed pending the outcome.
IIRM Holdings India Other Announcement
IIRM Holdings India Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026, as per regulatory requirements.
IIRM Holdings India Capital Structure Change
IIRM Holdings received trading approval for 15.6 lakh equity shares issued to non-promoter investors on a preferential basis. The shares are listed effective October 9, 2026.
- Value
- ₹22.35 Cr
IIRM Holdings India Capital Structure Change
IIRM Holdings India Ltd filed this shareholding pattern following the allotment of equity shares and convertible warrants through a preferential issue.
IIRM Holdings India Other Announcement
Carpediem Capital Partners Fund II acquired 11,67,295 equity shares and 66,14,671 convertible warrants in IIRM Holdings via preferential allotment. The non-promoter investor now holds 11.15% of voting capital.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr